Literature DB >> 30683905

Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation.

Michelle Schoettler1, Christine Duncan2, Leslie Lehmann2, Elissa Furutani2, Meera Subramaniam3, Steven Margossian2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30683905     DOI： 10.1038/s41409-019-0450-3

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  7 in total

1.  Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial.

Authors:  Liren Qian; Miao Liu; Jianliang Shen; Jian Cen; Defeng Zhao
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

2.  Ruxolitinib as an Effective and Steroid-Sparing First-Line Treatment in Newly Diagnosed BOS Patients After Hematopoietic Stem Cell Transplantation.

Authors:  Xiaoyu Zhang; Xiaoli Zhao; Yuyan Shen; Yuanyuan Shi; Lining Zhang; Mengze Hao; Fei Zhao; Rongli Zhang; Jialin Wei; Sizhou Feng; Yi He; Erlie Jiang; Mingzhe Han
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis.

Authors:  Guang-Qiang Meng; Yi-Ni Wang; Jing-Shi Wang; Zhao Wang
Journal:  Chin Med J (Engl)       Date:  2021-01-05       Impact factor: 2.628

Review 4.  New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions.

Authors:  Nathaniel Edward Bennett Saidu; Chiara Bonini; Anne Dickinson; Magdalena Grce; Marit Inngjerdingen; Ulrike Koehl; Antoine Toubert; Robert Zeiser; Sara Galimberti
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

Review 5.  Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions.

Authors:  Allan R Glanville; Christian Benden; Anne Bergeron; Guang-Shing Cheng; Jens Gottlieb; Erika D Lease; Michael Perch; Jamie L Todd; Kirsten M Williams; Geert M Verleden
Journal:  ERJ Open Res       Date:  2022-07-25

6.  Hydrogen-Rich Water Ameliorates Murine Chronic Graft-versus-Host Disease through Antioxidation.

Authors:  Liren Qian; Jiaxin Liu; Weina Ma; Yu Liu; Xiaona Wang; Daihong Liu
Journal:  Oxid Med Cell Longev       Date:  2021-10-14       Impact factor: 6.543

Review 7.  New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.

Authors:  Annalisa Marcuzzi; Erika Rimondi; Elisabetta Melloni; Arianna Gonelli; Antonio Giacomo Grasso; Egidio Barbi; Natalia Maximova
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.